| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |